Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: Taiwan Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20041
20051
20065
20072
20081
20094
20105
20113
20121
20132
20142
20161
20172
20201
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S16
AstraZeneca9
Eli Lilly and Company6
Takeda2
Bristol-Myers Squibb1
China Medical University Hospital1
Energenesis Biomedical Co., Ltd.1
National Health Research Institutes, Taiwan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus37
Diabetes Mellitus, Type 228
Diabetes Mellitus, Type 13
Cardiovascular Diseases2
Glucose Metabolism Disorders2
Metabolic Diseases2
Pulmonary Disease, Chronic Obstructive2
Acute Coronary Syndrome1
Asthma1
Coronary Artery Disease1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.